⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2630112 | 1.00 | — | — | |
| SCHEMBL2630131 | 1.00 | — | — | |
| SCHEMBL2630040 | 0.90 | — | — | |
| SCHEMBL2630140 | 0.87 | PLK4 (0.55) | — | |
| SCHEMBL2630132 | 0.87 | PLK4 (0.55) | — | |
| SCHEMBL2630171 | 0.87 | PLK4 (0.46) | — | |
| SCHEMBL14236213 | 0.86 | JAK3 (0.45) | — | |
| SCHEMBL14236251 | 0.86 | JAK3 (0.45) | — | |
| SCHEMBL14951784 | 0.86 | JAK3 (0.57) | — | |
| SCHEMBL2630150 | 0.86 | JAK3 (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013173506-A2 | METHOD OF TREATING MUSCULAR DEGRADATION | RIGEL PHARMACEUTICALS, INC. (US) | 2013-11-21 | — | — | WO | disclosed |
| US-20120165307-A1 | AZAINDOLES USEFUL AS INHIBITORS OF JANUS KINASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-06-28 | — | — | US | disclosed |
| US-20120165307-A1 | AZAINDOLES USEFUL AS INHIBITORS OF JANUS KINASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-06-28 | — | — | US | disclosed |